The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
Approval Biosimilar Notice Implicates Millions
1 min
Related Services
Related Insights
Stay on Top of Hot Topics in Patent Damages Litigation
Stay on Top of Hot Topics in Patent Damages Litigation
April 18, 2024
1min
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction
April 17, 2024
2min
Genentech and Dr. Reddy’s Settle BPCIA Litigation Against Proposed Rituxan Biosimilar DRL_RI
Genentech and Dr. Reddy’s Settle BPCIA Litigation Against Proposed Rituxan Biosimilar DRL_RI
April 15, 2024
1min
Events
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
AI in Pharma: Transforming Life Sciences IP and Reshaping the Hatch-Waxman Litigation Landscape
April 25 - 26, 2024 New York, NY - American Conference Institute
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
Michael Joblove and Nina Greene to Speak at IFA Legal Symposium
May 05 - 07, 2024 Washington, DC
Patent Damages: What is Really at Stake?
Patent Damages: What is Really at Stake?
May 14, 2024 Ashburn, VI - IPWatchdog
Recent News
American University Washington College of Law Alumni Association to Present Claudia Lewis with the Joseph H. Hairston Award on April 20
American University Washington College of Law Alumni Association to Present Claudia Lewis with the Joseph H. Hairston Award on April 20
April 19, 2024
1min
WAVe Presents: A Supreme Court Outlook and the Legacy of Ruth Bader Ginsburg
WAVe Presents: A Supreme Court Outlook and the Legacy of Ruth Bader Ginsburg
April 19, 2024
4min
Variety Spotlights Three Venable Attorneys in Its 2024 Legal Impact Report
Variety Spotlights Three Venable Attorneys in Its 2024 Legal Impact Report
April 17, 2024
1min